REG - MavIncGroVCT4 MavIncGroVCT4. - Issue of Equity

Maven Income and Growth VCT 4Announcement

07/10/2022 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221007:nRSG1652Ca&default-theme=true

RNS Number : 1652C  Maven Income & Growth VCT 4 PLC  07 October 2022

Maven Income and Growth VCT 4 PLC

 

Issue of Equity - Dividend Investment Scheme

 

 

The Board of Maven Income and Growth VCT 4 PLC (the Company) confirms that, on
7 October 2022 and under its Dividend Investment Scheme (DIS), the Company
issued and allotted 396,967 new ordinary shares of 10p each (Ordinary Shares)
at a price of 66.56p per share which, under the Terms and Conditions of the
DIS, is equivalent to the latest announced net asset value per share.

 

As a result, and in accordance with the Financial Conduct Authority's
Disclosure, Guidance and Transparency Rules, the Company confirms that its
issued share capital as at 7 October 2022 comprises  130,810,046 Ordinary
Shares, with each share carrying one voting right. The above figure may be
used by Shareholders as the denominator for the calculations by which they
will determine if they are required, under the Disclosure, Guidance and
Transparency Rules, to notify their interest, or a change to their interest,
in the Company.

 

Application has been made to the FCA and the London Stock Exchange for the new
Ordinary Shares issued under the DIS to be admitted to the Official List and
to trading on the London Stock Exchange's main market for listed securities.
It is expected that admission will become effective and dealings will commence
on, or around, 12 October 2022.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

7 October 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEUPGBCUUPPURM